2022-10-04 07:39:01 BHVN Biohaven
Pfizer
10/04/22 10/0407:39 10/04/2207:39 | Biohaven launches as a new publicly traded companyBiohaven (BHVN) launched as a new publicly traded company. As of today, Biohaven has officially begun operating as a separate independent entity as part of the acquisition agreement with Pfizer (PFE) in May 2022. The company, led by Vlad Coric, M.D. as Chairman and Chief Executive Officer, launched with approximately $257.8 million in cash at the distribution and no debt. Biohaven has a history of successful drug development and commercialization. The FDA filed and accepted for review Biohaven's New Drug Application submission for zavegepant nasal spray with a Prescription Drug User Fee Act goal date set for the first quarter of 2023. With the acquisition by Pfizer for a total consideration of approximately $13B including payoff of existing debt, Pfizer will now exclusively commercialize and develop the Biohaven CGRP franchise globally. Pfizer owns approximately 3% of the new spinoff company Biohaven. Advancing a Broad Portfolio of Innovative Candidates: Biohaven plans to advance a broad portfolio of early- and late-stage innovative product candidates targeting neurological and neuropsychiatric diseases, including rare disorders with unmet medical needs. Therapeutic development will focus on treatments for epilepsy, pain and mood disorders, obsessive compulsive disorder, spinocerebellar ataxia and spinal muscular atrophy. Key clinical development programs underway that leverage these proprietary technology platforms, include the following: Glutamate modulation for SCA and OCD; Myostatin inhibition for neuromuscular diseases, and potentially for diabetes and weight loss; Novel immune modulation platform targeting CD-38 for multiple myeloma Team executives: The Biohaven Board of Directors remains the same. Irfan Qureshi, M.D. is promoted to Chief Medical Officer, previously Senior Vice President of Neurology at Biohaven. And Tanya Fischer, M.D., Ph.D. is appointed Chief Development Officer and Head of Translational Medicine, previously at Alnylam Pharmaceuticals (ALNY). Bruce Car, Ph.D. joins Biohaven as the new Chief Scientific Officer. Dr. Car brings more than 28 years of experience in the pharmaceutical industry having held numerous scientific leadership positions at Bristol-Myers Squibb (BMY). Biohaven
Pfizer
Alnylam
Bristol-Myers
|
|
---|
Options
|
Mattel options imply 6.2% move in share price post-earnings »
15:04 02/08/23 02/0815:04 02/08/2315:04
MAT
Mattel
Pre-earnings options… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Zur Rose Group price target raised to CHF 60 from CHF 30 at Berenberg »
15:00 02/08/23 02/0815:00 02/08/2315:00
ZRSEF
Zur Rose Group
Berenberg analyst Gerhard… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Ubisoft price target lowered to EUR 23 from EUR 42 at Berenberg »
15:00 02/08/23 02/0815:00 02/08/2315:00
UBSFY
Ubisoft
Berenberg analyst Jamie… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Stillfront Group price target lowered to SEK 35 from SEK 45 at Berenberg »
14:59 02/08/23 02/0814:59 02/08/2314:59
STLFF
Stillfront Group
Berenberg analyst Edward… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Scor price target raised to EUR 29.50 from EUR 28 at Berenberg »
14:59 02/08/23 02/0814:59 02/08/2314:59
SCRYY
Scor
Berenberg analyst Michael… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Linea Directa price target lowered to EUR 0.95 from EUR 1.02 at Berenberg »
14:58 02/08/23 02/0814:58 02/08/2314:58
LNDAF
Linea Directa
Berenberg analyst Thomas… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Engie SA price target lowered to EUR 15.50 from EUR 16 at Berenberg »
14:58 02/08/23 02/0814:58 02/08/2314:58
ENGIY
Engie SA
Berenberg lowered the… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Embracer Group price target lowered to SEK 110 from SEK 150 at Berenberg »
14:57 02/08/23 02/0814:57 02/08/2314:57
THQQF
Embracer Group
Berenberg analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Aedifica price target lowered to EUR 110 from EUR 130 at Berenberg »
14:57 02/08/23 02/0814:57 02/08/2314:57
AEDFF
Aedifica
Berenberg analyst Kai… Story temporarily locked. ShowHide Related Items >><<
|
Options
|
Viking Therapeutics options imply 11.2% move in share price post-earnings »
14:49 02/08/23 02/0814:49 02/08/2314:49
VKTX
Viking Therapeutics
Pre-earnings options… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
B. Riley Financial exec Moore acquires 20,000 common shares »
14:48 02/08/23 02/0814:48 02/08/2314:48
RILY
B. Riley Financial
In a regulatory filing,… Story temporarily locked. ShowHide Related Items >><<
|
General news
|
Fed Governor Waller added to the hawkish rhetoric »
14:45 02/08/23 02/0814:45 02/08/2314:45
$ECON
Economic Data
Fed Governor Waller added… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
M&G Plc price target lowered to 247 GBp from 270 GBp at Morgan Stanley »
14:34 02/08/23 02/0814:34 02/08/2314:34
MGPUF
M&G Plc
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Options
|
Plains All American options imply 2.7% move in share price post-earnings »
14:34 02/08/23 02/0814:34 02/08/2314:34
PAA
Plains All American
Pre-earnings options… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Legal & General price target lowered to 285 GBp from 295 GBp at Morgan Stanley »
14:33 02/08/23 02/0814:33 02/08/2314:33
LGGNY
Legal & General
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Digital Brands CEO says can't issue new capital raising equity for next 90 days »
14:33 02/08/23 02/0814:33 02/08/2314:33
DBGI
Digital Brands
Hil Davis, CEO of Digital… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Google announces AI-powered Immersive View for Maps »
14:32 02/08/23 02/0814:32 02/08/2314:32
GOOG
Alphabet
Alphabet
Google announces… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Aviva price target lowered to 520 GBp from 540 GBp at Morgan Stanley »
14:31 02/08/23 02/0814:31 02/08/2314:31
AVVIY
Aviva
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
TeamViewer price target raised to EUR 13 from EUR 12.50 at Morgan Stanley »
14:31 02/08/23 02/0814:31 02/08/2314:31
TMVWY
TeamViewer
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Star Equity Holdings Inc trading resumes
14:30 02/08/23 02/0814:30 02/08/2314:30
|
Upgrade
|
Harmonic Drive upgraded to Buy from Neutral at Goldman Sachs »
14:27 02/08/23 02/0814:27 02/08/2314:27
HSYDF
Harmonic Drive
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
KPN price target raised to EUR 3.70 from EUR 3.60 at Morgan Stanley »
14:27 02/08/23 02/0814:27 02/08/2314:27
KKPNY
KPN
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Grifols price target raised to EUR 16 from EUR 14 at Morgan Stanley »
14:26 02/08/23 02/0814:26 02/08/2314:26
GRFS
Grifols
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Dominion takes $1.5B charge on nonregulated solar facilities »
14:22 02/08/23 02/0814:22 02/08/2314:22
D
Dominion
Dominion Energy said… Story temporarily locked. ShowHide Related Items >><<
|
Options
|
Digital Turbine options imply 15.5% move in share price post-earnings »
14:19 02/08/23 02/0814:19 02/08/2314:19
APPS
Digital Turbine
Pre-earnings options… Story temporarily locked. ShowHide Related Items >><<
|